Compugen reported $647.62M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 1.34B 1.1B Aug/2026
Bio Path USD 0 1000K Aug/2026
Brainstorm Cell Therapeutics USD 43M 32M Aug/2026
Cara Therapeutics USD 110M 80M Aug/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
Immunic USD 64M 23M Dec/2025
RedHill Biopharma USD 1000K 4M Jul/2026